TVI-Brain-1, Radiotherapy, Temozolomide — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Ne
Phase 2/3 · Glioblastoma Multiforme of Brain |
TVAX Biomedical | TVI-Brain-1, Radiotherapy, Temozolomide |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|